Modeling Peak Expiratory Flow in Patients With Asthma and Quantifying Treatment Effects Using a Mixed-Effects Hidden Markov Model.

Jakobsson L, Baaz M, Leander J, Gerlee P, Jirstrand M.

Open source

DOI
10.1002/psp4.70281
Published
2026-06-01
Container
CPT Pharmacometrics Syst Pharmacol
Publisher
Not recorded
Open access
yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1002/psp4.70281,
  title = {Modeling Peak Expiratory Flow in Patients With Asthma and Quantifying Treatment Effects Using a Mixed-Effects Hidden Markov Model.},
  author = {Jakobsson L and  Baaz M and  Leander J and  Gerlee P and  Jirstrand M.},
  year = {2026},
  journal = {CPT Pharmacometrics Syst Pharmacol},
  doi = {10.1002/psp4.70281},
  url = {https://doi.org/10.1002/psp4.70281}
}

RIS

TY  - JOUR
TI  - Modeling Peak Expiratory Flow in Patients With Asthma and Quantifying Treatment Effects Using a Mixed-Effects Hidden Markov Model.
AU  - Jakobsson L
AU  -  Baaz M
AU  -  Leander J
AU  -  Gerlee P
AU  -  Jirstrand M.
PY  - 2026
JO  - CPT Pharmacometrics Syst Pharmacol
DO  - 10.1002/psp4.70281
UR  - https://doi.org/10.1002/psp4.70281
ER  - 

APA

L, J., M, B., J, L., P, G., & M., J. (2026). Modeling Peak Expiratory Flow in Patients With Asthma and Quantifying Treatment Effects Using a Mixed-Effects Hidden Markov Model.. CPT Pharmacometrics Syst Pharmacol. https://doi.org/10.1002/psp4.70281

Source records